Showing results (1921-1930 of 2,286) with videos related to
Sort By:
Pageof 229
Surgery|October 3, 2006
Experience with dual kidney transplants from donors at the extremes of agePhillip S Moore, Alan C Farney, Aimee K Sundberg, et al.Australian Veterinary Journal|January 31, 2009
Equine amnionitis and fetal loss: the case definition for an unrecognised cause of abortion in maresK H Todhunter, N R Perkins, R M Wylie, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing RadiotherapyDaniel L Adams, Diane K Adams, Jianzhong He, et al.Journal of Anatomy|August 19, 2014
On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritisA Boyde, G R Davis, D Mills, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 17, 2017
PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's diseaseAlastair J Noyce, Lea R'Bibo, Luisa Peress, et al.Sensors (Basel, Switzerland)|September 14, 2024
Wearable Sensor-Based Assessments for Remotely Screening Early-Stage Parkinson's DiseaseShane Johnson, Michalis Kantartjis, Joan Severson, et al.The Journal of Clinical Endocrinology and Metabolism|April 26, 2021
Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin ResistanceIsabel Huang-Doran, Alexandra B Kinzer, Mercedes Jimenez-Linan, et al.American Journal of Pharmaceutical Education|December 5, 2017
Report of the 2016-2017 Student Affairs Standing CommitteeRenae J Chesnut, Iqbal I Atcha, Duc P Do, et al.Breast Cancer Research and Treatment|August 13, 2016
Vigorous physical activity and risk of breast cancer in the African American breast cancer epidemiology and risk consortiumZhihong Gong, Chi-Chen Hong, Elisa V Bandera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapyR J Schilder, J M Gallo, M M Millenson, et al.Pageof 229